Friday, August 10, 2007

WSJ Health Blog: Not So Bland Afterall!

Have you noticed a change in the WSJ Health Blog after I commented that "Frankly, aside from the headlines, it's a little bland"?

Take today's post, "John Johnson Leaving Johnson & Johnson", for example. Let me reproduce the whole thing here:

John Johnson is leaving Johnson & Johnson to run ImClone Systems.

No word on whether John H. Johnson (pictured, left) is related to Robert Wood Johnson (pictured, right) or Edward Mead Johnson, founders of Johnson & Johnson.

But regardless of any connections among Messrs. Johnson, we have to wonder whether Johnson will be glad to be free of the possible confusion of being John Johnson at Johnson & Johnson. (We called Johnson & Johnson and got John Johnson's voicemail, but didn't hear back.)

We checked in with Avery Johnson, WSJ's Johnson & Johnson reporter (who doesn't think she's related to Johnson, Johnson or Johnson), but our Johnson hadn't spoken with John Johnson.

What we do know is that Johnson, 49, has been company group chairman of J&J's world-wide biopharmaceuticals unit. He starts his job at ImClone later this month.

Financier and ImClone chairman Carl Icahn welcomed Johnson aboard. "We look forward to working with him to take the company to the next level," Icahn said in a statement.
Now that's funny!

The post was made by Jacob Goldstein. Nice job!


Matt @ Green and Gold Rugby said...

Hi John,

Just noticed the link to future of pharma marketing

Thanks for the link. There's one back to you and more content going on now.


Anonymous said...

You are truly delusional if you think that they changed the blog because of your post

PharmaGuy said...

And you are truly without any sense of humor!